Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ORTHOCON logo — company profile

ORTHOCON

Founded 2005 United States Irvington, United States 4 employees Venture round Total: $47.50M Biotechnology, Health Care +1

General Information

Company Name ORTHOCON
Founded Year 2005
Location United States Irvington, United States
Employees 4
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with ORTHOCON. To contact ORTHOCON, visit orthocon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ORTHOCON compare?

A PDF of ORTHOCON and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ORTHOCON soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ORTHOCON

Orthocon is a biotechnology and health care startup that was founded in 2005 and is headquartered in the United States. The company develops, manufactures, markets, and sells innovative surgical products designed to stop bleeding from and deliver drugs to bone. In 2010, Orthocon successfully launched its first FDA-cleared product, the HEMASORB Absorbable Bone Hemostat Matrix.

Orthocon received a $12.50M Venture Round investment on 31 December 2009 from Canaan Partners and ProQuest Investments. The company firmly believes that its products have the potential to provide significant benefits to millions of patients each year, positioning it as a promising venture for potential investors.

Business keywords: startup, therapeutic devices, surgical products, FDA-cleared, hemostat, surgical innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $12.50M 2
Canaan Partners ProQuest Investments
Canaan Partners, ProQuest Investments
31 Dec 2009
Series B $25.00M 3
Canaan Partners ProQuest Investments BB Biotech Ventures
Canaan Partners, ProQuest Investments +1
08 Apr 2009
Series A $10.00M 2
Canaan Partners BB Biotech Ventures
Canaan Partners, BB Biotech Ventures
23 Feb 2006

ORTHOCON Alternatives & Competitors

View All Alternatives
ORTHOCON vs
EndoGastric Solutions
EndoGastric Solutions United States

TIF Procedure for Reflux

Venture round
38 employees
Health Care, Medical Devices
ORTHOCON vs
IlluminOss Medical Inc.
IlluminOss Medical Inc. United States

World's first patient-conforming intramedullary implant using balloons, light activated monomers and...

Venture round
35 employees
Health Care, Manufacturing
ORTHOCON vs
Hubly Surgical
Hubly Surgical United States

FDA Cleared Hubly Drill: intracranial drill with SMART Auto-Stop and LED force indication designed f...

Seed
16 employees
Health Care, Medical Devices
View all alternatives

FAQ About ORTHOCON

Founded in 2005, ORTHOCON is a startup therapeutic device company that develops, manufactures, markets and sells innovative surgical products that stop the bleeding from and deliver drugs to bone. In 2010, ORTHOCON launched its first FDA-cleared product, the HEMASORB Absorbable Bone Hemostat Matrix....
ORTHOCON was founded in 2005.
ORTHOCON is headquartered in Irvington, United States.
ORTHOCON operates in Biotechnology, Health Care and Medical Devices. Its work centres on startup, therapeutic devices, surgical products and FDA-cleared.
ORTHOCON has approximately 4 employees.
ORTHOCON has completed 3 funding rounds, raising a total of $47.50M. The latest funding stage is Venture round.
Top alternatives and competitors to ORTHOCON include EndoGastric Solutions, IlluminOss Medical Inc., Hubly Surgical, Shape Memory Medical Inc., Andrew Technologies LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ORTHOCON and EndoGastric Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ORTHOCON, https://bouncewatch.com/company/orthocon, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes